Anaerobe-Targeted Antibiotic Therapy in the Neonatal Intensive Care Unit.

IF 2.5 4区医学 Q3 INFECTIOUS DISEASES

Journal of the Pediatric Infectious Diseases Society Pub Date : 2025-01-20 DOI:10.1093/jpids/piae109

Matthew B Green, Alvaro Zevallos Barboza, Sagori Mukhopadhyay, Jeffrey S Gerber, Michael J Morowitz, Karen M Puopolo, Dustin D Flannery

引用次数: 0

Abstract

Anaerobe-targeted antibiotic (ATA) therapy may adversely impact the developing neonatal microbiome. We describe utilization patterns, potential indications, and related outcomes of ATA therapy in neonatal intensive care units across the United States over 13 years. While overall antibiotic use decreased, ATA use was unchanged. Potentially associated indications were inconsistent.

查看原文本刊更多论文

新生儿重症监护室的厌氧菌靶向抗生素疗法。

厌氧菌靶向抗生素（ATA）疗法可能会对新生儿发育中的微生物组产生不利影响。我们描述了 13 年来全美新生儿重症监护病房中 ATA 治疗的使用模式、潜在适应症和相关结果。虽然抗生素的总体使用量有所下降，但 ATA 的使用量没有变化。潜在的相关适应症并不一致。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of the Pediatric Infectious Diseases Society Medicine-Pediatrics, Perinatology and Child Health

CiteScore

6.70

自引率

0.00%

发文量

179

期刊介绍： The Journal of the Pediatric Infectious Diseases Society (JPIDS), the official journal of the Pediatric Infectious Diseases Society, is dedicated to perinatal, childhood, and adolescent infectious diseases. The journal is a high-quality source of original research articles, clinical trial reports, guidelines, and topical reviews, with particular attention to the interests and needs of the global pediatric infectious diseases communities.